Parliament

Gordon Campbell | Parliament TV | Parliament Today | Video | Questions Of the Day | Search

 

$200 million group B meningococcal campaign

Health Minister Annette King today announced a commitment of up to $200 million to the Meningococcal Vaccine Strategy to be funded over a five-year period, with $35 million to be spent in 2002-03.

Ms King said New Zealand was experiencing a group B meningococcal epidemic. “Over the past 11 years more than 4300 New Zealanders have contracted the disease, up to 20 per cent of whom have been left with serious physical or mental disability, including brain damage, deafness, loss of limbs or damaged skin requiring extensive skin grafts,” Ms King said.

Rates continue to be high in 2002 with no sign of the epidemic waning.

Earlier this year, the government pledged more than $100m to develop, trial and deliver a vaccine to target New Zealand’s specific strain of group B meningococcal, and in March signed an agreement with Californian-based Chiron Corporation.

“Our short-term aim is to assess a New Zealand specific vaccine suitable for an immunisation campaign. Our long-term aim is to rid New Zealand of this epidemic. To achieve this we aim to vaccinate at least 90 per cent of New Zealanders under 20.

“This is an ambitious and expensive exercise. We estimate the total cost will be $149 million over the next three years and up to $200 million over the next five years. Funds are required to develop a vaccine, run clinical trials, delivery the vaccine to the target population and encourage New Zealanders to be immunized against the disease.

“Clinical trials are planned to start at the end of this month. Following regulatory approval of the vaccine, a nationwide immunisation campaign will be undertaken.

“This government is committed to addressing this problem that has caused so much heartache for many New Zealand families,” Ms King said.

Ends

© Scoop Media

 
 
 
Parliament Headlines | Politics Headlines | Regional Headlines

 

Dealing Crackdown, Addiction Support: Government Action On Synthetics

The NZ Drug Foundation has welcomed the Government’s response to synthetic drug deaths. The response strikes a balance between giving law enforcement the tools they need to target criminal networks and changing drug law to make it easier for people to access help when they need it. More>>

ALSO:

Strategy Committee Unanimous: Wellington To Forge Ahead With Convention Centre

The three-storey Cable Street building, with around 18,000-square metres of floor space, will comfortably be able to host 1500 people for conventions. It includes a 1651sq m exhibition area that will attract international exhibitions too big for nearby Te Papa and provide an always-changing visitor attraction. More>>

ALSO:

Surveying The Surveillance: First IGIS Review Of Warrants Under New Act

The report sets out the Inspector-General’s interpretation of the new warrant provisions under the ISA and her expectations of the GCSB and NZSIS when they prepare warrant applications. More>>

SSC: 2018 Public Service Workforce Data Published

State Services Commissioner Peter Hughes has published the 2018 Our People, Public Service Workforce Data , which shows the Public Service is making significant progress in important areas. More>>

ALSO:

Sinking Cap: Auctions, Permanent Forests, Added To ETS

The move to auctions, signalled in an August consultation paper, will help put a cap on the number of emission units available over time. Annual announcements, looking forward five years, will help provide certainty for scheme participants, she said. More>>

ALSO:

Joint Select Committee Report: Achieving Smokefree 2025

In a historic first for select committees, the Māori Affairs Committee and the Health Committee presented their joint report on achieving the Smokefree 2025 goal to the House on Tuesday, 11 December 2018. More>>

"Shared Interests And Democratic Values": Peters To Visit USA

Deputy Prime Minister and Foreign Affairs Minister Winston Peters will travel to Washington D.C. for talks with US Secretary of State Michael R. Pompeo and other senior members of the US Administration. More>>

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 
 

InfoPages News Channels